{"DataElement":{"publicId":"7181407","version":"1","preferredName":"Participant Chronic Lymphocytic Leukemia International Prognostic Index Risk Score Status Stratification Code","preferredDefinition":"The stratification code associated with a participant's CLL-IPI risk score status.","longName":"7181402v1.0:7181404v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"7181402","version":"1","preferredName":"Participant Chronic Lymphocytic Leukemia International Prognostic Index Risk Score Status","preferredDefinition":"Someone who takes part in an activity._The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)_A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))_The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._A number or range of numeric values measuring performance, function, quality, or ability._A condition or state at a particular time.","longName":"2407061v1.0:7181400v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2407061","version":"1","preferredName":"Participant","preferredDefinition":"Someone who takes part in an activity.","longName":"C29867","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Participant","conceptCode":"C29867","definition":"Someone who takes part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-49C5-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7181400","version":"1","preferredName":"Chronic Lymphocytic Leukemia International Prognostic Index Risk Score Status","preferredDefinition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001):A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org)):The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:A number or range of numeric values measuring performance, function, quality, or ability.:A condition or state at a particular time.","longName":"7181400v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"International Prognostic Index","conceptCode":"C20118","definition":"A list of five factors that help doctors assess how a non-Hodgkin lymphoma patient might respond to a certain treatment or predict the risk of disease recurrence and survival following therapy.  The factors are: 1) patient's age, 2) stage of disease: an indication of how localized or widespread is the disease, 3) LDH levels: serum levels often correlate with the amount of tumor in the body, 4) the number of extranodal, non-lymphatic sites found, 5) the patient's overall health. (from Lymphoma Research Foundation of America glossary (www.lymphoma.org))","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F0947A0-C749-2FBA-E053-F662850A54DE","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F0947A0-C75A-2FBA-E053-F662850A54DE","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"KEARNSD","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7181404","version":"1","preferredName":"Risk Score Stratification Code","preferredDefinition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._A number or range of numeric values measuring performance, function, quality, or ability._The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"7181404v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"2","valueDescription":"Very High Risk (>= 7 points or complex cytogenetics)","ValueMeaning":{"publicId":"7181405","version":"1","preferredName":"Very High Risk (>= 7 points or complex cytogenetics)","longName":"7181405","preferredDefinition":"Very High Risk (>= 7 points or complex cytogenetics)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F086395-E854-41AC-E053-F662850A6AE1","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F086395-E86D-41AC-E053-F662850A6AE1","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","deletedIndicator":"No"},{"value":"1","valueDescription":"High Risk (4-6 points)","ValueMeaning":{"publicId":"7181406","version":"1","preferredName":"High Risk (4-6 points)","longName":"7181406","preferredDefinition":"High Risk (4-6 points)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F086395-E877-41AC-E053-F662850A6AE1","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F086395-E890-41AC-E053-F662850A6AE1","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7181403","version":"1","preferredName":"Risk Score Stratification Code","preferredDefinition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:A number or range of numeric values measuring performance, function, quality, or ability.:The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C17102:C25338:C25689:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F086395-E82F-41AC-E053-F662850A6AE1","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"ONEDATA","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F086395-E840-41AC-E053-F662850A6AE1","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"KEARNSD","dateModified":"2020-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811952","version":"1","longName":"Cytogenetics","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the participant's CLL","type":"Preferred Question Text","description":"What is the participant's CLL-IPI risk score status?","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F0947A0-C772-2FBA-E053-F662850A54DE","latestVersionIndicator":"Yes","beginDate":"2020-02-20","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-02-20","modifiedBy":"KEARNSD","dateModified":"2020-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}